
2025-11-19 05:06:40
重(zhong)組人(ren)SLAMF1蛋(dan)白(bai)(bai)(bai)(bai)是一(yi)種在(zai)哺乳動(dong)(dong)物細(xi)(xi)(xi)(xi)(xi)胞(bao)中表(biao)達的(de)(de)(de)重(zhong)組蛋(dan)白(bai)(bai)(bai)(bai),主要(yao)(yao)包含SLAMF1的(de)(de)(de)胞(bao)外(wai)區,融(rong)合(he)(he)了hFc標簽,便于(yu)純(chun)化(hua)和(he)檢測。SLAMF1(Signaling Lymphocyte Activation Molecule Family Member 1),也(ye)稱(cheng)為CD150,是一(yi)種共刺激(ji)分(fen)子(zi)(zi),廣表(biao)達于(yu)免(mian)(mian)(mian)(mian)(mian)(mian)疫細(xi)(xi)(xi)(xi)(xi)胞(bao)(如T細(xi)(xi)(xi)(xi)(xi)胞(bao)、B細(xi)(xi)(xi)(xi)(xi)胞(bao)和(he)巨噬細(xi)(xi)(xi)(xi)(xi)胞(bao))表(biao)面(mian),通(tong)過(guo)同(tong)型(xing)(xing)或(huo)異型(xing)(xing)相(xiang)互(hu)作(zuo)用調節免(mian)(mian)(mian)(mian)(mian)(mian)疫細(xi)(xi)(xi)(xi)(xi)胞(bao)的(de)(de)(de)啟(qi)(qi)動(dong)(dong)和(he)信(xin)(xin)號(hao)轉導(dao)(dao)。SLAMF1的(de)(de)(de)功(gong)能與(yu)機制SLAMF1在(zai)免(mian)(mian)(mian)(mian)(mian)(mian)疫細(xi)(xi)(xi)(xi)(xi)胞(bao)的(de)(de)(de)啟(qi)(qi)動(dong)(dong)和(he)信(xin)(xin)號(hao)轉導(dao)(dao)中發揮重(zhong)要(yao)(yao)作(zuo)用。它通(tong)過(guo)與(yu)自身或(huo)其他SLAM家(jia)族成員(如SLAMF4、SLAMF6)結合(he)(he),傳遞啟(qi)(qi)動(dong)(dong)信(xin)(xin)號(hao),促進免(mian)(mian)(mian)(mian)(mian)(mian)疫細(xi)(xi)(xi)(xi)(xi)胞(bao)的(de)(de)(de)增殖(zhi)、分(fen)化(hua)和(he)細(xi)(xi)(xi)(xi)(xi)胞(bao)因子(zi)(zi)分(fen)泌。SLAMF1的(de)(de)(de)信(xin)(xin)號(hao)轉導(dao)(dao)依賴于(yu)其胞(bao)內段的(de)(de)(de)免(mian)(mian)(mian)(mian)(mian)(mian)疫受體酪氨酸啟(qi)(qi)動(dong)(dong)基序(ITAM),啟(qi)(qi)動(dong)(dong)后可(ke)招募(mu)多種信(xin)(xin)號(hao)分(fen)子(zi)(zi),如Syk和(he)PI3K,進而調節免(mian)(mian)(mian)(mian)(mian)(mian)疫反應(ying)。此外(wai),SLAMF1在(zai)免(mian)(mian)(mian)(mian)(mian)(mian)疫細(xi)(xi)(xi)(xi)(xi)胞(bao)間的(de)(de)(de)相(xiang)互(hu)作(zuo)用中也(ye)起到關鍵作(zuo)用,影響免(mian)(mian)(mian)(mian)(mian)(mian)疫細(xi)(xi)(xi)(xi)(xi)胞(bao)的(de)(de)(de)協同(tong)啟(qi)(qi)動(dong)(dong)和(he)免(mian)(mian)(mian)(mian)(mian)(mian)疫應(ying)答(da)。重(zhong)組人(ren)SLAMF1蛋(dan)白(bai)(bai)(bai)(bai)的(de)(de)(de)特點重(zhong)組人(ren)SLAMF1蛋(dan)白(bai)(bai)(bai)(bai)具有以下(xia)明顯特點:高純(chun)度:純(chun)度≥95%(經SDS-PAGE和(he)SEC-HPLC驗證),確保(bao)實驗結果的(de)(de)(de)可(ke)靠(kao)性。低內素:內素水平<0.1 EU/μg,適合(he)(he)用于(yu)細(xi)(xi)(xi)(xi)(xi)胞(bao)實驗和(he)體內研(yan)究。功(gong)能完整(zheng):保(bao)留了天然SLAMF1的(de)(de)(de)結合(he)(he)位點和(he)信(xin)(xin)號(hao)轉導(dao)(dao)功(gong)能。由于(yu)Pfu DNA Polymerase 對引(yin)(yin)物的(de)(de)(de)質(zhi)量要(yao)(yao)求較高,使用純(chun)度高的(de)(de)(de)引(yin)(yin)物可(ke)以減(jian)少由于(yu)引(yin)(yin)物錯誤(wu)導(dao)(dao)致(zhi)的(de)(de)(de)非目(mu)標突變。PKG Substrate

重組(zu)人(ren)TNFSF15蛋白(bai)(HisTag)是(shi)一種(zhong)在哺乳(ru)動(dong)(dong)物細(xi)(xi)(xi)胞(bao)(bao)(bao)中(zhong)表達的(de)(de)(de)(de)重組(zu)蛋白(bai),融合了His標簽,便于純(chun)化和(he)(he)檢測。TNFSF15(TumorNecrosisFactorSuperfamilyMember15),也稱為VEGI(VascularEndothelialGrowthInhibitor),是(shi)TNF超(chao)家族(zu)的(de)(de)(de)(de)重要成員,廣參與免(mian)(mian)疫(yi)調(diao)節(jie)(jie)、炎(yan)癥(zheng)(zheng)反(fan)應和(he)(he)血管(guan)生(sheng)成的(de)(de)(de)(de)調(diao)控。它在多種(zhong)生(sheng)物學過程(cheng)中(zhong)發揮關(guan)鍵(jian)作(zuo)(zuo)用(yong),尤(you)其(qi)是(shi)在免(mian)(mian)疫(yi)細(xi)(xi)(xi)胞(bao)(bao)(bao)的(de)(de)(de)(de)啟(qi)動(dong)(dong)和(he)(he)組(zu)織修(xiu)復過程(cheng)中(zhong)。TNFSF15的(de)(de)(de)(de)功(gong)能與機制(zhi)(zhi)TNFSF15通(tong)過其(qi)胞(bao)(bao)(bao)外區與受體(ti)(如TNFRSF25)結(jie)合,啟(qi)動(dong)(dong)下(xia)游的(de)(de)(de)(de)信(xin)號(hao)通(tong)路。TNFSF15的(de)(de)(de)(de)信(xin)號(hao)轉(zhuan)導(dao)依賴于其(qi)受體(ti)的(de)(de)(de)(de)胞(bao)(bao)(bao)內(nei)(nei)段結(jie)構域,能夠啟(qi)動(dong)(dong)NF-κB、MAPK和(he)(he)JNK等信(xin)號(hao)通(tong)路,進而調(diao)節(jie)(jie)細(xi)(xi)(xi)胞(bao)(bao)(bao)的(de)(de)(de)(de)存(cun)活、增殖和(he)(he)炎(yan)癥(zheng)(zheng)反(fan)應。在免(mian)(mian)疫(yi)系(xi)統中(zhong),TNFSF15通(tong)過啟(qi)動(dong)(dong)免(mian)(mian)疫(yi)細(xi)(xi)(xi)胞(bao)(bao)(bao)(如T細(xi)(xi)(xi)胞(bao)(bao)(bao)和(he)(he)樹突狀細(xi)(xi)(xi)胞(bao)(bao)(bao)),促進免(mian)(mian)疫(yi)反(fan)應。此外,TNFSF15在血管(guan)生(sheng)成中(zhong)也發揮重要作(zuo)(zuo)用(yong),通(tong)過抑制(zhi)(zhi)血管(guan)內(nei)(nei)皮細(xi)(xi)(xi)胞(bao)(bao)(bao)的(de)(de)(de)(de)增殖和(he)(he)遷(qian)移,調(diao)節(jie)(jie)血管(guan)的(de)(de)(de)(de)形(xing)成。TNFSF15的(de)(de)(de)(de)功(gong)能異常與多種(zhong)疾(ji)(ji)病(bing)相關(guan),如自身(shen)免(mian)(mian)疫(yi)性(xing)疾(ji)(ji)病(bing)、炎(yan)癥(zheng)(zheng)性(xing)疾(ji)(ji)病(bing)和(he)(he)瘤。重組(zu)人(ren)TNFSF15蛋白(bai)(HisTag)的(de)(de)(de)(de)特(te)(te)點重組(zu)人(ren)TNFSF15蛋白(bai)(HisTag)具(ju)有以下(xia)明顯(xian)特(te)(te)點:高純(chun)度:純(chun)度≥95%(經SDS-PAGE和(he)(he)SEC-HPLC驗證(zheng)),確(que)保(bao)實驗結(jie)果(guo)的(de)(de)(de)(de)可(ke)靠(kao)性(xing)。低內(nei)(nei)素:內(nei)(nei)素水(shui)平<0.1EU/μg,適合用(yong)于細(xi)(xi)(xi)胞(bao)(bao)(bao)實驗和(he)(he)體(ti)內(nei)(nei)研究。BclI它會在識別(bie)到該序列后,在“^”標記的(de)(de)(de)(de)位(wei)置將 DNA 鏈切(qie)斷,產生(sheng)黏(nian)性(xing)末(mo)端。

重組人(ren)TNFRSF11A蛋(dan)(dan)白是(shi)一種在哺乳動物細(xi)(xi)(xi)胞(bao)(bao)中表(biao)達的(de)(de)(de)重組蛋(dan)(dan)白,融合(he)了(le)hFc標簽,便(bian)于(yu)純化和(he)(he)檢(jian)測。TNFRSF11A(Tumor Necrosis Factor Receptor Superfamily Member 11A),也稱為(wei)RANK(Receptor Activator of Nuclear Factor-κB),是(shi)TNF受體超(chao)家(jia)族的(de)(de)(de)重要成員,廣參與(yu)(yu)骨(gu)代謝和(he)(he)免(mian)疫調(diao)節(jie)(jie)。它在調(diao)節(jie)(jie)骨(gu)吸(xi)收、免(mian)疫細(xi)(xi)(xi)胞(bao)(bao)分化和(he)(he)組織修復中發(fa)揮關鍵作(zuo)用(yong)。TNFRSF11A的(de)(de)(de)功(gong)能與(yu)(yu)機制TNFRSF11A通過(guo)其胞(bao)(bao)外區與(yu)(yu)配(pei)體RANKL(Receptor Activator of Nuclear Factor-κB Ligand)結合(he),啟(qi)動下(xia)游的(de)(de)(de)信(xin)號通路。RANKL主要由(you)成骨(gu)細(xi)(xi)(xi)胞(bao)(bao)和(he)(he)免(mian)疫細(xi)(xi)(xi)胞(bao)(bao)分泌,通過(guo)與(yu)(yu)RANK結合(he),調(diao)節(jie)(jie)破骨(gu)細(xi)(xi)(xi)胞(bao)(bao)的(de)(de)(de)分化和(he)(he)活性(xing)(xing),促進骨(gu)吸(xi)收。此(ci)外,TNFRSF11A還參與(yu)(yu)調(diao)節(jie)(jie)免(mian)疫細(xi)(xi)(xi)胞(bao)(bao)的(de)(de)(de)分化和(he)(he)功(gong)能,如(ru)樹突狀細(xi)(xi)(xi)胞(bao)(bao)的(de)(de)(de)成熟和(he)(he)T細(xi)(xi)(xi)胞(bao)(bao)的(de)(de)(de)活化。TNFRSF11A的(de)(de)(de)功(gong)能異(yi)常與(yu)(yu)多種疾病相(xiang)關,如(ru)骨(gu)質疏松癥、骨(gu)硬(ying)化癥和(he)(he)某些自身免(mian)疫性(xing)(xing)疾病。重組人(ren)TNFRSF11A蛋(dan)(dan)白(hFc Tag)的(de)(de)(de)特(te)點(dian)重組人(ren)TNFRSF11A蛋(dan)(dan)白(hFc Tag)具有(you)以下(xia)明顯特(te)點(dian):高純度(du):純度(du)≥95%(經SDS-PAGE和(he)(he)SEC-HPLC驗證),確保實驗結果的(de)(de)(de)可靠性(xing)(xing)。低(di)內(nei)素:內(nei)素水平(ping)<0.1 EU/μg,適合(he)用(yong)于(yu)細(xi)(xi)(xi)胞(bao)(bao)實驗和(he)(he)體內(nei)研究。功(gong)能完(wan)整(zheng):保留了(le)天然TNFRSF11A的(de)(de)(de)配(pei)體結合(he)位點(dian)和(he)(he)信(xin)號轉導功(gong)能。
重(zhong)(zhong)組(zu)人潛(qian)伏(fu)性(xing)(xing)TGF-β3蛋(dan)(dan)白(Recombinant Human Latent TGF-β3 Protein, His Tag)是一種重(zhong)(zhong)要(yao)的(de)(de)(de)(de)多(duo)功能細(xi)胞因子復(fu)合物(wu),屬于轉化(hua)生長因子-β(TGF-β)超(chao)家族成(cheng)員。TGF-β3與(yu)(yu)(yu)TGF-β1、TGF-β2同屬TGF-β亞型,廣參與(yu)(yu)(yu)胚(pei)胎(tai)發育、組(zu)織(zhi)修(xiu)復(fu)、細(xi)胞分化(hua)及免(mian)疫調節等生理過程(cheng)。潛(qian)伏(fu)性(xing)(xing)TGF-β3由成(cheng)熟(shu)TGF-β3肽段與(yu)(yu)(yu)其(qi)潛(qian)伏(fu)相關(guan)肽(Latency-Associated Peptide, LAP)通(tong)(tong)過非共價(jia)鍵(jian)結(jie)合形(xing)成(cheng),是TGF-β3在(zai)體內的(de)(de)(de)(de)主要(yao)存在(zai)形(xing)式,能夠維持(chi)其(qi)非活性(xing)(xing)狀態,防止過早啟動。該(gai)重(zhong)(zhong)組(zu)蛋(dan)(dan)白通(tong)(tong)常采(cai)用真(zhen)核表達系統(tong)(如(ru)CHO細(xi)胞或HEK293細(xi)胞)制(zhi)備,確保了(le)其(qi)天然構象和(he)(he)(he)(he)生物(wu)活性(xing)(xing)。其(qi)N端融合了(le)His標(biao)簽,便(bian)于通(tong)(tong)過Ni-NTA親和(he)(he)(he)(he)層析(xi)進(jin)行高效純化(hua),獲得高純度、高穩定(ding)性(xing)(xing)的(de)(de)(de)(de)蛋(dan)(dan)白產物(wu)。這(zhe)種設計不(bu)僅提高了(le)蛋(dan)(dan)白的(de)(de)(de)(de)溶(rong)解性(xing)(xing)和(he)(he)(he)(he)穩定(ding)性(xing)(xing),也方(fang)便(bian)了(le)后(hou)續的(de)(de)(de)(de)實驗操作(zuo),如(ru)ELISA、Western blot、免(mian)疫沉淀及蛋(dan)(dan)白相互作(zuo)用研(yan)(yan)究等。研(yan)(yan)究表明,TGF-β3在(zai)胚(pei)胎(tai)發育、組(zu)織(zhi)修(xiu)復(fu)及免(mian)疫穩態維持(chi)中具(ju)有(you)獨特(te)作(zuo)用,其(qi)異(yi)常表達與(yu)(yu)(yu)發育異(yi)常、纖維化(hua)疾病及病進(jin)展密(mi)切相關(guan)。因此(ci),重(zhong)(zhong)組(zu)人潛(qian)伏(fu)性(xing)(xing)TGF-β3蛋(dan)(dan)白不(bu)僅是研(yan)(yan)究TGF-β信(xin)號通(tong)(tong)路的(de)(de)(de)(de)重(zhong)(zhong)要(yao)工具(ju),也為開發相關(guan)疾病的(de)(de)(de)(de)治策略提供了(le)有(you)力(li)支持(chi),具(ju)有(you)重(zhong)(zhong)要(yao)的(de)(de)(de)(de)科研(yan)(yan)和(he)(he)(he)(he)臨床應用價(jia)值(zhi)。E1通(tong)(tong)常被認為是泛素(su)化(hua)過程(cheng)中的(de)(de)(de)(de)限速步(bu)驟,因為它涉(she)及到泛素(su)的(de)(de)(de)(de)激起和(he)(he)(he)(he)ATP的(de)(de)(de)(de)水(shui)解。

重(zhong)組(zu)人KIR2DL2蛋(dan)白(bai)(Recombinant Human KIR2DL2 Protein, His-Avi Tag)是一種重(zhong)要(yao)的(de)(de)免(mian)(mian)疫(yi)(yi)調(diao)節分子(zi)(zi),屬(shu)于(yu)殺(sha)傷細(xi)(xi)胞(bao)免(mian)(mian)疫(yi)(yi)球蛋(dan)白(bai)樣受體(ti)(Killer-cell Immunoglobulin-like Receptor, KIR)家(jia)族(zu)成(cheng)員,主要(yao)表(biao)(biao)(biao)達于(yu)自(zi)然殺(sha)傷細(xi)(xi)胞(bao)(NK細(xi)(xi)胞(bao))和部分T細(xi)(xi)胞(bao)表(biao)(biao)(biao)面(mian)。KIR2DL2通過識(shi)別并結合(he)(he)靶(ba)細(xi)(xi)胞(bao)表(biao)(biao)(biao)面(mian)的(de)(de)HLA-C分子(zi)(zi),傳遞抑制性(xing)信號(hao),從而(er)抑制NK細(xi)(xi)胞(bao)的(de)(de)細(xi)(xi)胞(bao)毒(du)活性(xing),在(zai)維持(chi)免(mian)(mian)疫(yi)(yi)耐受、抗(kang)病(bing)毒(du)免(mian)(mian)疫(yi)(yi)及(ji)腫瘤免(mian)(mian)疫(yi)(yi)監視(shi)中發揮(hui)關(guan)鍵作用(yong)(yong)(yong)(yong)。該重(zhong)組(zu)蛋(dan)白(bai)采(cai)用(yong)(yong)(yong)(yong)真核(he)表(biao)(biao)(biao)達系統(如HEK293細(xi)(xi)胞(bao))制備,確保了(le)其天然構象和生(sheng)(sheng)物活性(xing)。其N端融合(he)(he)了(le)His標簽,便于(yu)通過Ni-NTA親和層析進行高(gao)效純化(hua)(hua);同時(shi)帶有Avi標簽,可(ke)在(zai)體(ti)內(nei)或體(ti)外(wai)通過生(sheng)(sheng)物素(su)(su)連接酶實(shi)現(xian)特(te)異性(xing)生(sheng)(sheng)物素(su)(su)化(hua)(hua),極大(da)提高(gao)了(le)其在(zai)ELISA、表(biao)(biao)(biao)面(mian)等離子(zi)(zi)共振(SPR)及(ji)流(liu)式細(xi)(xi)胞(bao)術等實(shi)驗中的(de)(de)應用(yong)(yong)(yong)(yong)靈活性(xing)。KIR2DL2在(zai)免(mian)(mian)疫(yi)(yi)治(zhi)研(yan)究中具(ju)有重(zhong)要(yao)意(yi)義,尤其在(zai)NK細(xi)(xi)胞(bao)功能調(diao)控、腫瘤免(mian)(mian)疫(yi)(yi)逃逸機制及(ji)個體(ti)化(hua)(hua)免(mian)(mian)疫(yi)(yi)治(zhi)策略開發中受到廣關(guan)注。重(zhong)組(zu)人KIR2DL2蛋(dan)白(bai)為研(yan)究NK細(xi)(xi)胞(bao)與靶(ba)細(xi)(xi)胞(bao)相互作用(yong)(yong)(yong)(yong)、篩選KIR-HLA阻(zu)斷劑及(ji)開發新型免(mian)(mian)疫(yi)(yi)檢查點抑制劑提供了(le)可(ke)靠工(gong)具(ju),具(ju)有重(zhong)要(yao)的(de)(de)科研(yan)與臨床轉化(hua)(hua)價值(zhi)。SpCas9-NLS的(de)(de)應用(yong)(yong)(yong)(yong)范圍廣泛(fan),可(ke)用(yong)(yong)(yong)(yong)于(yu)細(xi)(xi)胞(bao)內(nei)的(de)(de)CRISPR/Cas9系統介(jie)導的(de)(de)基因(yin)編(bian)輯。Recombinant Cynomolgus RGM-C Protein,His Tag
Taq PCR Master Mix (2×) (Without Dye) 是一種即(ji)用(yong)型的2倍濃度預(yu)混液,廣泛應用(yong)于(yu)常(chang)規(gui)PCR擴增(zeng)。PKG Substrate
重(zhong)(zhong)(zhong)組人(ren)Tenascin蛋(dan)(dan)白(bai)(bai)(bai)(His Tag)是一(yi)種(zhong)在哺(bu)乳(ru)動(dong)物細(xi)(xi)胞(bao)(bao)(bao)(bao)(bao)中表(biao)達的(de)(de)(de)重(zhong)(zhong)(zhong)組蛋(dan)(dan)白(bai)(bai)(bai),融合(he)(he)了His標簽,便于(yu)純化(hua)和(he)檢測(ce)。Tenascin是一(yi)種(zhong)大型細(xi)(xi)胞(bao)(bao)(bao)(bao)(bao)外基(ji)(ji)質糖蛋(dan)(dan)白(bai)(bai)(bai),廣參與細(xi)(xi)胞(bao)(bao)(bao)(bao)(bao)黏附(fu)、遷(qian)移、增(zeng)殖(zhi)和(he)分化(hua)等生(sheng)物學過(guo)程(cheng),在胚胎發(fa)育(yu)、組織修(xiu)復和(he)瘤(liu)發(fa)生(sheng)中發(fa)揮重(zhong)(zhong)(zhong)要作用(yong)(yong)(yong)。Tenascin的(de)(de)(de)功能與機制Tenascin通過(guo)其多(duo)個結構(gou)(gou)(gou)域(如EGF樣結構(gou)(gou)(gou)域、纖維素(su)樣結構(gou)(gou)(gou)域)與其他(ta)細(xi)(xi)胞(bao)(bao)(bao)(bao)(bao)外基(ji)(ji)質蛋(dan)(dan)白(bai)(bai)(bai)(如膠原(yuan)蛋(dan)(dan)白(bai)(bai)(bai)、纖連(lian)蛋(dan)(dan)白(bai)(bai)(bai))相互(hu)作用(yong)(yong)(yong),調(diao)節細(xi)(xi)胞(bao)(bao)(bao)(bao)(bao)外基(ji)(ji)質的(de)(de)(de)組裝和(he)重(zhong)(zhong)(zhong)塑。此(ci)外,Tenascin還通過(guo)與細(xi)(xi)胞(bao)(bao)(bao)(bao)(bao)表(biao)面受體(如整合(he)(he)素(su))結合(he)(he),影響細(xi)(xi)胞(bao)(bao)(bao)(bao)(bao)的(de)(de)(de)黏附(fu)、遷(qian)移和(he)增(zeng)殖(zhi)。在胚胎發(fa)育(yu)過(guo)程(cheng)中,Tenascin對身體形(xing)成和(he)組織分化(hua)至關(guan)重(zhong)(zhong)(zhong)要。在瘤(liu)發(fa)生(sheng)中,Tenascin的(de)(de)(de)異常表(biao)達與瘤(liu)的(de)(de)(de)侵襲性(xing)和(he)轉移能力密切相關(guan)。重(zhong)(zhong)(zhong)組人(ren)Tenascin蛋(dan)(dan)白(bai)(bai)(bai)(His Tag)的(de)(de)(de)特(te)點重(zhong)(zhong)(zhong)組人(ren)Tenascin蛋(dan)(dan)白(bai)(bai)(bai)(His Tag)具有以下明顯特(te)點:高(gao)純度:純度≥95%(經(jing)SDS-PAGE和(he)SEC-HPLC驗證),確(que)保實(shi)(shi)(shi)驗結果的(de)(de)(de)可靠性(xing)。低(di)內(nei)素(su):內(nei)素(su)水平<0.1 EU/μg,適合(he)(he)用(yong)(yong)(yong)于(yu)細(xi)(xi)胞(bao)(bao)(bao)(bao)(bao)實(shi)(shi)(shi)驗和(he)體內(nei)研究。功能完整:保留了天然(ran)Tenascin的(de)(de)(de)結構(gou)(gou)(gou)域和(he)細(xi)(xi)胞(bao)(bao)(bao)(bao)(bao)外基(ji)(ji)質相互(hu)作用(yong)(yong)(yong)功能。實(shi)(shi)(shi)驗應用(yong)(yong)(yong)重(zhong)(zhong)(zhong)組人(ren)Tenascin蛋(dan)(dan)白(bai)(bai)(bai)(His Tag)在多(duo)種(zhong)實(shi)(shi)(shi)驗中表(biao)現出色:流(liu)式(shi)細(xi)(xi)胞(bao)(bao)(bao)(bao)(bao)術:檢測(ce)Tenascin在細(xi)(xi)胞(bao)(bao)(bao)(bao)(bao)表(biao)面或細(xi)(xi)胞(bao)(bao)(bao)(bao)(bao)外基(ji)(ji)質中的(de)(de)(de)表(biao)達水平。PKG Substrate